Year |
Citation |
Score |
2023 |
Régnier P, Vetillard M, Bansard A, Pierre E, Li X, Cagnard N, Gautier EL, Guermonprez P, Manoury B, Podsypanina K, Darrasse-Jèze G. FLT3L-dependent dendritic cells control tumor immunity by modulating Treg and NK cell homeostasis. Cell Reports. Medicine. 4: 101256. PMID 38118422 DOI: 10.1016/j.xcrm.2023.101256 |
0.412 |
|
2017 |
Filipescu D, Naughtin M, Podsypanina K, Lejour V, Wilson L, Gurard-Levin ZA, Orsi GA, Simeonova I, Toufektchan E, Attardi LD, Toledo F, Almouzni G. Essential role for centromeric factors following p53 loss and oncogenic transformation. Genes & Development. PMID 28356341 DOI: 10.1101/Gad.290924.116 |
0.408 |
|
2015 |
Botta C, Darini C, Darrasse-Jèze G, Podsypanina K. Methods to study primary tumor cells and residual tumor cells in mouse models of oncogene dependence. Methods in Molecular Biology (Clifton, N.J.). 1267: 381-94. PMID 25636480 DOI: 10.1007/978-1-4939-2297-0_19 |
0.371 |
|
2013 |
Darrasse-Jèze G, Podsypanina K. How numbers, nature, and immune status of foxp3(+) regulatory T-cells shape the early immunological events in tumor development. Frontiers in Immunology. 4: 292. PMID 24133490 DOI: 10.3389/Fimmu.2013.00292 |
0.474 |
|
2010 |
Leslie K, Gao SP, Berishaj M, Podsypanina K, Ho H, Ivashkiv L, Bromberg J. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation. Breast Cancer Research : Bcr. 12: R80. PMID 20929542 DOI: 10.1186/Bcr2725 |
0.461 |
|
2010 |
Reddy JP, Peddibhotla S, Bu W, Zhao J, Haricharan S, Du YC, Podsypanina K, Rosen JM, Donehower LA, Li Y. Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation. Proceedings of the National Academy of Sciences of the United States of America. 107: 3728-33. PMID 20133707 DOI: 10.1073/Pnas.0910665107 |
0.532 |
|
2009 |
Darrasse-Jèze G, Bergot AS, Durgeau A, Billiard F, Salomon BL, Cohen JL, Bellier B, Podsypanina K, Klatzmann D. Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. The Journal of Clinical Investigation. 119: 2648-62. PMID 19652360 DOI: 10.1172/Jci36628 |
0.384 |
|
2009 |
Jechlinger M, Podsypanina K, Varmus H. Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction Genes and Development. 23: 1677-1688. PMID 19605689 DOI: 10.1101/Gad.1801809 |
0.417 |
|
2008 |
Podsypanina K, Du YCN, Jechlinger M, Beverly LJ, Hambardzumyan D, Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung Science. 321: 1841-1844. PMID 18755941 DOI: 10.1126/Science.1161621 |
0.452 |
|
2008 |
Podsypanina K, Politi K, Beverly LJ, Varmus HE. Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras. Proceedings of the National Academy of Sciences of the United States of America. 105: 5242-7. PMID 18356293 DOI: 10.1073/Pnas.0801197105 |
0.532 |
|
2008 |
Huang S, Chen Y, Podsypanina K, Li Y. Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice. Neoplasia (New York, N.Y.). 10: 118-24. PMID 18283333 DOI: 10.1593/Neo.07637 |
0.512 |
|
2006 |
Huang S, Podsypanina K, Chen Y, Cai W, Tsimelzon A, Hilsenbeck S, Li Y. Wnt-1 is dominant over neu in specifying mammary tumor expression profiles. Technology in Cancer Research & Treatment. 5: 565-71. PMID 17121432 DOI: 10.1177/153303460600500603 |
0.531 |
|
2006 |
Puc J, Placha G, Wocial B, Podsypanina K, Parsons R, Gaciong Z. Analysis of PTEN mutation in non-familial pheochromocytoma. Annals of the New York Academy of Sciences. 1073: 317-31. PMID 17102102 DOI: 10.1196/Annals.1353.037 |
0.634 |
|
2006 |
Du Z, Podsypanina K, Huang S, McGrath A, Toneff MJ, Bogoslovskaia E, Zhang X, Moraes RC, Fluck M, Allred DC, Lewis MT, Varmus HE, Li Y. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models. Proceedings of the National Academy of Sciences of the United States of America. 103: 17396-401. PMID 17090666 DOI: 10.1073/Pnas.0608607103 |
0.495 |
|
2005 |
Varmus H, Pao W, Politi K, Podsypanina K, Du YCN. Oncogenes come of age Cold Spring Harbor Symposia On Quantitative Biology. 70: 1-9. PMID 16869733 DOI: 10.1101/Sqb.2005.70.039 |
0.404 |
|
2005 |
Huang S, Li Y, Chen Y, Podsypanina K, Chamorro M, Olshen AB, Desai KV, Tann A, Petersen D, Green JE, Varmus HE. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice. Genome Biology. 6: R84. PMID 16207355 DOI: 10.1186/Gb-2005-6-10-R84 |
0.5 |
|
2005 |
Zhang X, Podsypanina K, Huang S, Mohsin SK, Chamness GC, Hatsell S, Cowin P, Schiff R, Li Y. Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations. Oncogene. 24: 4220-31. PMID 15824740 DOI: 10.1038/Sj.Onc.1208597 |
0.477 |
|
2004 |
Podsypanina K, Li Y, Varmus HE. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype. Bmc Medicine. 2: 24. PMID 15198801 DOI: 10.1186/1741-7015-2-24 |
0.577 |
|
2003 |
Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, Tan LK, Rosen JM, Varmus HE. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proceedings of the National Academy of Sciences of the United States of America. 100: 15853-8. PMID 14668450 DOI: 10.1073/Pnas.2136825100 |
0.523 |
|
2002 |
Wang H, Douglas W, Lia M, Edelmann W, Kucherlapati R, Podsypanina K, Parsons R, Ellenson LH. DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice. The American Journal of Pathology. 160: 1481-6. PMID 11943731 DOI: 10.1016/S0002-9440(10)62573-4 |
0.599 |
|
2001 |
Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression Proceedings of the National Academy of Sciences of the United States of America. 98: 11563-11568. PMID 11553783 DOI: 10.1073/Pnas.201167798 |
0.601 |
|
2001 |
Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J, Neshat M, Wang H, Yang L, Gibbons J, Frost P, Dreisbach V, Blenis J, Gaciong Z, Fisher P, et al. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 10320-5. PMID 11504907 DOI: 10.1073/Pnas.171060098 |
0.467 |
|
2001 |
Li Y, Podsypanina K, Liu X, Crane A, Tan LK, Parsons R, Varmus HE. Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice. Bmc Molecular Biology. 2: 2. PMID 11178110 DOI: 10.1186/1471-2199-2-2 |
0.662 |
|
2001 |
Li Y, Podsypanina K, Liu X, Crane A, Tan LK, Parsons R, Varmus HE. Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice Bmc Molecular Biology. 2. DOI: 10.1186/1471-2199-2-2 |
0.567 |
|
1999 |
Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems Proceedings of the National Academy of Sciences of the United States of America. 96: 1563-1568. PMID 9990064 DOI: 10.1073/Pnas.96.4.1563 |
0.634 |
|
1997 |
Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (New York, N.Y.). 275: 1943-7. PMID 9072974 DOI: 10.1126/Science.275.5308.1943 |
0.693 |
|
Show low-probability matches. |